2014 Symposium Agenda
16th Annual Lynn Sage Breast Cancer Breakout Sessions

Breakout Symposia are extra sessions available to registered participants of the Lynn Sage Breast Cancer Symposium for a $50 fee. You may purchase a meal ticket seperately for an additional $25 if you wish to eat during the presentation. Session seating is limited and advanced registration is required.

Information about this year's sessions will be posted here as it becomes available. Check back soon for more information.


Controversies in Local Therapy of Early Stage Breast Cancer – Case-based Discussion

Thursday, October 9, 12:00 p.m.

Presenters:

John Kim, MD
Plastic Surgeon
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Jonathan Strauss, MD
Radiation Oncologist
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Moderator:

Nora Hansen, MD
Breast Surgeon
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Objectives:

Learning objectives will be achieved utilizing clinical case studies to highlight common clinical dilemmas. At the completion of this session participants will be able to:

  • Cite the remaining controversies related to management of the axilla
  • Cite controversies involving reconstruction techniques and timing
  • Describe the role of local-regional radiotherapy in patients with SLN positive breast cancer
  • Explain the risk of local regional recurrence in patients with SLN-positive breast cancer

Do Molecular Assays Improve Breast Cancer Care? – Case-based Discussion

Friday, October 10, 12:45 p.m.

Presenters:

William Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Monica Morrow, MD
Memorial Sloan-Kettering Cancer Center

Objectives:

At the conclusion of this activity, participants will be able to:

  • Distinguish the differences between commercial available genomic assays
  • Cite the prognostic and predictive validity of available genomic assays
  • Describe how genomic assays have impacted on clinical decision making
  • Interpret how a genetic profile of a patient's tumor may impact on therapeutic choices

Supported in part by an educational grant from Genomic Health.


Accreditation Statement
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Hour Statement
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity


Use the hashtag #LSBC14 to follow and share updates from the 2014 Lynn Sage Breast Cancer Symposium

© Robert H. Lurie Comprehensive Cancer Center of Northwestern University